Emeis Share: Down 18.5% in One Month, the Nursing Home Operator Recovers 1.5%
After an uninterrupted decline over several weeks, the manager of elderly care facilities rebounds in early afternoon. The movement is of modest scale and leaves the stock far from its medium-term benchmarks, in a Paris session oriented upward.
A Modest Rebound After a Decline of More Than 26% in Three Months
The Emeis share gains 1.59% to €10.21 during the session, compared to €10.05 at the last close. This recovery remains slight given the 18.45% decline recorded over one month and 26.86% over three months. The stock ranks among gainers in the SBF 120, in an index advancing 0.41%.
The support level at €9.89, briefly touched and broken through on Friday, before being reclaimed at close, remains the level to watch. The RSI at 24 indicates an oversold configuration, a sign of a decline without any real relief. The 20-day moving average at €11.20 stands 8.84% above the current price, and the 200-day moving average at €13.81 stands 26.07% above.
A Half-Year Publication That Raises the Group's 2026 Guidance
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The group published its first-half 2026 results on July 29. It indicated that the half-year performance enabled an upward revision of its 2026 guidance, with the trend since the start of the year confirming the momentum observed in 2025 and even exceeding its initial expectations. Since this publication, the stock has nonetheless continued to decline, and disposals are ongoing: Emeis completed its withdrawal from Latin America in early October, for approximately €111 million in disposals excluding residual land.
Over one year, the share is down 31.93%. The resistance level at €13.19 is now far from the current price.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.